Rydx S&P Mc 400 Pure Grw

Nomura Holdings Inc. Raises Stake in Hims & Hers Health

Castleark Management LLC Invests $2.92 Million in Hims & Hers Health

Hims & Hers Health is expected to complete its acquisition of YourBio Health

Marex Group plc Invests $53.63 Million in Hims & Hers Health, Inc.

Cim LLC Acquired Exelixis, Inc. Stock in Q2

Jefferies analyst reiterates buy rating for MasTec

Braidwell LP Increased Holdings of Globus Medical in Q2

AQR Capital Management LLC Increased Holdings in Exelixis, Inc.

Hims & Hers Health Director Sells a Small Portion of Company Stock

Novo Nordisk confirms it is in preliminary talks with Hims & Hers to sell a weight-loss pill

Analysis questions if Hims & Hers Health is still attractive after its 450% stock surge

Roivant Sciences Ltd. Acquires Immunovant Inc.

Goldman Sachs Maintains Buy Rating on Roivant Sciences with a Price Target of $33

Hims & Hers Health Sees Significant Bearish Unusual Options Activity

Hims & Hers Expands Its Weight-Management Program to the United Kingdom

Qube Research & Technologies Ltd reduces holdings in American Comfort Systems

Roivant Sciences Executives Dispose of Company Common Stock

Brian J Marley of Carpenter Technology Sold 75,458 Shares

Hims & Hers announces it will lay off 68 employees, about 4% of its workforce.

PsiThera Raises $47.5 Million for AI-Designed Oral Drug Development

AdvisorShares MSOS 2x Daily ETF

cbdMD

Tryhard

Roundhill Cannabis ETF

Neo-Concept

Amplify Seymour Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Canopy Growth

RYTHM

Tilray Brands

EXEL

Cim LLC acquired 35,092 shares of Exelixis, Inc. (NASDAQ:EXEL) in Q2, valued at $1,547,000. Other institutional investors also increased their positions in Exelixis. The stock opened at $40.88 on Friday with a market cap of $10.96 billion. Exelixis reported strong Q3 earnings, with $0.78 EPS and $597.76 million in revenue. Insiders sold 245,235 shares last quarter. Analysts have given positive ratings and new price targets for the stock.

Market Beat

Exelixis

Cim LLC Acquires Shares of 35,092 Exelixis, Inc. $EXEL

Comfort Systems (NYSE:FIX) is one of the 10 Data Center Cooling Companies to Invest In . On December 5, Comfort Systems was selected to become a part of the S&P 500 index. The news came after the quarterly rebalancing of the index, meaning FIX will now be included in the S&P 500 index before the […]

Comfort Systems USA

S&P inclusion adds to the excitement around Comfort Systems (FIX) stock

Hotwire Pro Services LLC, based in Washington, has achieved an 86% first-time fix rate in HVAC operations using AI-driven technology. The system reduces downtime, costs, and boosts customer satisfaction by optimizing dispatch and predicting system failures. The AI platform enhances technician efficiency, compliance, and environmental accountability. Hotwire plans to expand its AI platform for energy management and pursue partnerships to promote sustainability and innovation in HVAC services.

Newsfile Corp.

Hotwire Pro Services Reports 86% First-Time Fix Rate Through AI-Driven HVAC Operations

Jefferies analyst Julien Dumoulin Smith reiterated a Buy rating on MasTec (MTZ), with shares closing at $221.01. The analyst consensus is a Strong Buy with an average price target of $248.18, indicating a 12.29% upside. Dumoulin Smith has an average return of 6.3% and a 53.91% success rate on recommended stocks.

Tip Ranks

Mastec

MasTec (MTZ) Gets a Buy from Jefferies

HIMS

Hims & Hers Health has surged 450.4% over three years, driven by telehealth expansion and high-profile launches. Despite recent pullbacks, the stock is up 47.7% year to date. The company scores 2/6 on undervaluation checks. A DCF analysis suggests the stock is undervalued by 35.8%, while a P/E ratio analysis indicates it is overvalued. The article explores different valuation approaches and highlights the risks and opportunities for investors.

Simplywall

Hims & Hers Health

Is Hims & Hers Health Still Attractive After Its 450% Surge and Telehealth Expansion?

GMED

Braidwell LP acquired 247,200 shares of Globus Medical, valued at $14.59 million, during Q2. Other hedge funds also adjusted their positions. Insiders sold shares worth $8 million. Analysts have mixed ratings, with a consensus of 'Moderate Buy' and an average target price of $93. Globus Medical's stock opened at $86.77, with a market cap of $11.61 billion. The company reported strong quarterly earnings, beating estimates with $1.18 EPS and $769.05 million revenue, up 22.9% YoY.

Globus Medical Inc 

Braidwell LP Purchases Shares of 247,200 Globus Medical, Inc. $GMED

AQR Capital Management LLC increased its stake in Exelixis, Inc. by 10.3% in Q2, owning 2.83% of the company. Exelixis reported strong Q2 earnings, beating estimates. Analysts have mixed ratings, with price targets between $35 and $48.

AQR Capital Management LLC Purchases 712,190 Shares of Exelixis, Inc. $EXEL

Haley Patrick J, Vice President of Exelixis Inc, filed a Form 144 with the SEC to sell 28,043 shares of restricted stock through Bank of America Merrill Lynch. The filing allows the sale within 90 days.

Reuters

VP Haley Files To Sell 28,043 Of Exelixis Inc [EXEL]

VP Haley Patrick J of Exelixis Inc filed a Form 144 with the SEC to sell 10,648 restricted shares through Fidelity Investments, with the sale date set for November 20, 2025. This filing allows the sale within 90 days.

VP Haley Files To Sell 10,648 Of Exelixis Inc [EXEL]

Haley Patrick J, Vice President of Exelixis Inc, filed a Form 144 with the SEC to sell 23,539 shares of restricted securities through Bank of America Merrill Lynch. The filing allows the sale within 90 days from December 12, 2025. This action is part of insider trading regulations.

VP Haley Files To Sell 23,539 Of Exelixis Inc [EXEL]

IMVT

ROIV

Roivant Sciences Ltd Beneficial Owner of Immunovant Inc [IMVT] filed a Form 4 on December 12, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date12/12/25TransactionPurchaseShares16,666,666Price$21.00Value$349,999,986Ending Holdings: 113,317,007 - DirectFor a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

Immunovant

Roivant Sciences

Owner Roivant Sciences Ltd Buys 16,666,666 ($350M) Of Immunovant Inc [IMVT]

Roivant Sciences Ltd. has acquired common shares of Immunovant Inc., as reported in a recent SEC filing. This acquisition was disclosed by Immunovant Inc. through the EDGAR system on December 12, 2025. The information is provided by Public Technologies (PUBT) and is for informational purposes only.

Roivant Sciences Ltd. Reports Acquisition of Immunovant Inc. Common Shares

Goldman Sachs analyst Corinne Johnson maintained a Buy rating on Roivant Sciences with a $33 price target. Johnson, who covers the Healthcare sector, has a 7.5% average return and a 54.07% success rate. H.C. Wainwright also issued a Buy rating, while TR | OpenAI reiterated a Hold rating on Roivant Sciences.

Goldman Sachs Keeps Their Buy Rating on Roivant Sciences (ROIV)

Qube Research & Technologies Ltd reduced its stake in Comfort Systems USA by 60.1% in Q2, selling 151,138 shares. Comfort Systems USA's stock opened at $1,024.44, with a market cap of $36.13 billion. Insiders sold 26,028 shares worth $25,381,151 in the last three months. The company reported $0.90 EPS for Q2 and increased its quarterly dividend to $0.60.

Qube Research & Technologies Ltd Sells 151,138 Shares of Comfort Systems USA, Inc. $FIX

Carpenter Technology Insider Sold Shares Worth $23,001,396, According to a Recent SEC Filing

marketscreener

Carpenter Tech

Carpenter Technology Insider Sold Shares Worth $23,001,396, According to a Recent SEC Filing